What do we need to obtain high quality circulating tumor DNA (ctDNA) for routine diagnostic test in oncology? – Considerations on pre-analytical aspects by the IFCC workgroup cfDNA

This publication has 24 references indexed in Scilit:

• Prenatal Diagnosis Innovation: Genome Sequencing of Maternal Plasma
  Annual Review of Medicine, 2016
• Cell‐free circulating tumour DNA as a liquid biopsy in breast cancer
  Molecular Oncology, 2015
• Circulating Tumor DNA as a Liquid Biopsy for Cancer
  Clinical Chemistry, 2015
• Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
  Annals of Oncology, 2014
• Towards standardisation of cell-free DNA measurement in plasma: controls for extraction efficiency, fragment size bias and quantification
  Analytical and Bioanalytical Chemistry, 2014
• Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
  Science Translational Medicine, 2014
• Optimizing blood collection, transport and storage conditions for cell free DNA increases access to prenatal testing
  Clinical Biochemistry, 2013
• Circulating Cell-Free DNA from Colorectal Cancer Patients May Reveal High KRAS or BRAF Mutation Load
  Translational Oncology, 2013
• Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
  New England Journal of Medicine, 2013
• Characterization of circulating DNA in healthy human plasma
  Clinica Chimica Acta, 2008